Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients.
- Authors
- Hasin, Deborah S; Fenton, Miriam C; Beseler, Cheryl; Park, Jung Yeon; Wall, Melanie M
- Year
- 2012
- Journal
- Drug and alcohol dependence
- PMID
- 21963333
- DOI
- 10.1016/j.drugalcdep.2011.09.005
- PMCID
- PMC3755770
BACKGROUND: A number of changes have been proposed and investigated in the criteria for substance use disorders in DSM-5. However, although clinical utility of DSM-5 is a high priority, relatively little of the empirical evidence supporting the changes was obtained from samples of substance abuse patients. METHODS: Proposed changes were examined in 663 patients in treatment for substance use disorders, evaluated by experienced clinicians using the Psychiatric Research Interview for Substance and Mental Disorders (PRISM). Factor and item response theory analysis was used to investigate the dimensionality and psychometric properties of alcohol, cannabis, cocaine and heroin abuse and dependence criteria, and craving. RESULTS: The seven dependence criteria, three of the abuse criteria (hazardous use; social/interpersonal problems related to use; neglect of roles to use), and craving form a unidimensional latent trait for alcohol, cannabis, cocaine and heroin. Craving did not add significantly to the total information offered by the dependence criteria, but adding the three abuse criteria and craving together did significantly increase total information for the criteria sets associated with alcohol, cannabis and heroin. CONCLUSION: Among adult patients in treatment for substance disorders, the alcohol, cannabis, cocaine and heroin criteria for dependence, abuse (with the exception of legal problems), and craving measure a single underlying dimension. Results support the proposal to combine abuse and dependence into a single diagnosis in the DSM-5, omitting legal problems. Mixed support was provided for the addition of craving as a new criterion, warranting future studies of this important construct in substance use disorders.
Distribution of total counts of dependence and abuse criteria excluding legal problems but including craving.
Item characteristic curves models of alcohol, cannabis, cocaine and heroin dependence and abuse criteria (excluding legal problems) and including craving in a clinical sample. tolerance; withdrawal; larger/longer; quit/control; time spent; activ given up; physical/psych; neglect roles; hazardous use; social/interpers; -*- craving.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Craving in eating disorders: Mapping the concept through a systematic review. | Cornil A et al. | β | 2026 | β |
| Dysregulation of Plasma Growth Factors and Chemokines in Cocaine Use Disorder: Implications for Dual Diagnosis with Schizophrenia and Antisocial Personality Disorder in an Exploratory Study. | Torres-GalvΓ‘n S et al. | β | 2024 | β |
| Opioid use disorder (OUD) and treatment for opioid problems among OUD symptom subtypes in individuals misusing opioids. | Miller EA et al. | β | 2024 | β |
| Pharmacokinetics-Informed Neural Network for Predicting Opioid Administration Moments with Wearable Sensors. | Gullapalli BT et al. | β | 2024 | β |
| Virtual reality cue-exposure therapy in reducing cocaine craving: the Promoting Innovative COgnitive behavioral therapy for Cocaine use disorder (PICOC) study protocol for a randomized controlled trial. | Lehoux T et al. | β | 2024 | β |
| Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. | Shmulewitz D et al. | β | 2023 | β |
| Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample. | Chapron SA et al. | β | 2023 | β |
| Operational definitions and measurement of externalizing behavior problems: An integrative review including research models and clinical diagnostic systems. | Torres-Rosado L et al. | β | 2023 | β |
| Phenome-wide Association Analysis of Substance Use Disorders in a Deeply Phenotyped Sample. | Kember RL et al. | β | 2023 | β |
| Prevalence and correlates of DSM-5 opioid withdrawal syndrome in U.S. adults with non-medical use of prescription opioids: results from a national sample. | Mannes ZL et al. | β | 2023 | β |
| Psychometric Performance of a Substance Use Symptom Checklist to Help Clinicians Assess Substance Use Disorder in Primary Care. | Matson TE et al. | β | 2023 | β |
| Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids). | Shmulewitz D et al. | β | 2023 | β |
| A neuroeconomic signature of opioid craving: How fluctuations in craving bias drug-related and nondrug-related value. | Biernacki K et al. | β | 2022 | β |
| Applying network analysis to investigate substance use symptoms associated with drug overdose. | Ingram PF et al. | β | 2022 | β |
| Reliability of Differential Item Functioning in Alcohol Use Disorder: Bayesian Meta-Analysis of Criteria Discrimination Estimates. | Vize CE et al. | β | 2022 | β |
| Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance users. | Livne O et al. | β | 2021 | β |
| An instrument for visual cue associated craving of HEroin (IV-CACHE): A preliminary functional neuroimaging-based study of validity and reliability. | Shukla S et al. | β | 2021 | β |
| Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach. | Kervran C et al. | β | 2021 | β |
| Effectiveness and Acceptance of a Smartphone-Based Virtual Agent Screening for Alcohol and Tobacco Problems and Associated Risk Factors During COVID-19 Pandemic in the General Population. | Auriacombe M et al. | β | 2021 | β |
| Symptom networks in patients with substance use disorders. | Rutten RJT et al. | β | 2021 | β |
| The Etiologic, Theory-Based, Ontogenetic Hierarchical Framework of Alcohol Use Disorder: A Translational Systematic Review of Reviews. | Boness CL et al. | β | 2021 | β |
| Transdiagnostic connectome-based prediction of craving | Garrison KA et al. | β | 2021 | β |
| Is craving a risk factor for substance use among treatment-seeking individuals with alcohol and other drugs use disorders? A meta-analytic review. | Cavicchioli M et al. | β | 2020 | β |
| Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special? | Kervran C et al. | β | 2020 | β |
| Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: Results from a large-scale nationally representative study. | Feingold D et al. | β | 2020 | β |
| Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview. | Hasin D et al. | β | 2020 | β |
| A clinical evaluation of the DSM-5 criteria for Internet Gaming Disorder and a pilot study on their applicability to further Internet-related disorders. | MΓΌller KW et al. | β | 2019 | β |
| An Item Response Theory Analysis of <i>DSM-5</i> Heroin Use Disorder in a Clinical Sample of Chinese Adolescents. | Yang H et al. | β | 2019 | β |
| Auditory mismatch detection, distraction, and attentional reorientation (MMN-P3a-RON) in neurological and psychiatric disorders: A review. | Justo-GuillΓ©n E et al. | β | 2019 | β |
| Evaluation of the psychometric properties of the cannabis use disorders identification test - revised among college students. | Schultz NR et al. | β | 2019 | β |
| Examining the relation of personality factors to substance use disorder by explanatory item response modeling of DSM-5 symptoms. | Chen F et al. | β | 2019 | β |
| Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective? | Marsden J et al. | β | 2019 | β |
| Craving as a DSM-5 Symptom of Alcohol Use Disorder in Non-Treatment Seekers. | Hartwell EE et al. | β | 2018 | β |
| Drug use on both sides of the US-Mexico border. | Borges G et al. | β | 2018 | β |
| Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control. | Orenstein DG et al. | β | 2018 | β |
| Association of Specific Traumatic Experiences With Alcohol Initiation and Transitions to Problem Use in European American and African American Women. | Werner KB et al. | β | 2016 | β |
| Clinical utility of a single-item test for DSM-5 alcohol use disorder among outpatients with anxiety and depressive disorders. | Bartoli F et al. | β | 2016 | β |
| Concordance of ICD-11 and DSM-5 definitions of alcohol and cannabis use disorders: a population survey. | Lago L et al. | β | 2016 | β |
| Determining optimal diagnostic criteria through chronicity and comorbidity. | Steinley D et al. | β | 2016 | β |
| Differences in childhood physical abuse reporting and the association between CPA and alcohol use disorder in European American and African American women. | Werner KB et al. | β | 2016 | β |
| Heroin craving and its correlations with clinical outcome indicators in people with heroin dependence receiving methadone maintenance treatment. | Yen CF et al. | β | 2016 | β |
| Item Response Theory Analysis to Assess Dimensionality of Substance Use Disorder Abuse and Dependence Symptoms. | Kirisci L et al. | β | 2016 | β |
| Meta-analysis of DSM alcohol use disorder criteria severities: structural consistency is only 'skin deep'. | Lane SP et al. | β | 2016 | β |
| Substance Use and Cumulative Exposure to American Society: Findings From Both Sides of the US-Mexico Border Region. | Borges G et al. | β | 2016 | β |
| The Classification of Substance Use Disorders: Historical, Contextual, and Conceptual Considerations. | Robinson SM et al. | β | 2016 | β |
| Acute immunomodulatory effects of binge alcohol ingestion. | Afshar M et al. | β | 2015 | β |
| Childhood adversity moderates the effect of ADH1B on risk for alcohol-related phenotypes in Jewish Israeli drinkers. | Meyers JL et al. | β | 2015 | β |
| Childhood maltreatment, 9/11 exposure, and latent dimensions of psychopathology: A test of stress sensitization. | Meyers JL et al. | β | 2015 | β |
| Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects. | Shmulewitz D et al. | β | 2015 | β |
| Co-occurrence of alcohol, drug use, DSM-5 alcohol use disorder, and symptoms of drug use disorder on both sides of the U.S.-Mexico border. | Borges G et al. | β | 2015 | β |
| Does DSM-5 nomenclature for inhalant use disorder improve upon DSM-IV? | Ridenour TA et al. | β | 2015 | β |
| DSM-5 SUD diagnoses: changes, reactions, remaining open questions. | Hasin D | β | 2015 | β |
| DSM-IV and DSM-5 alcohol use disorder among young Swiss men. | Mohler-Kuo M et al. | β | 2015 | β |
| From DSM-IV to DSM-5 alcohol use disorder: an overview of epidemiological data. | Bartoli F et al. | β | 2015 | β |
| Heart rate variability biofeedback: Theoretical basis, delivery, and its potential for the treatment of substance use disorders. | Eddie D et al. | β | 2015 | β |
| Inter-observer reliability of DSM-5 substance use disorders. | Denis CM et al. | β | 2015 | β |
| Latent class analysis of DSM-5 criteria for opioid use disorders: results from the Iranian National Survey on Mental Health. | Tarrahi MJ et al. | β | 2015 | β |
| Limits of Current Approaches to Diagnosis Severity Based on Criterion Counts: An Example with DSM-5 Alcohol Use Disorder. | Lane SP et al. | β | 2015 | β |
| Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Goldstein RB et al. | β | 2015 | β |
| Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates. | Boscarino JA et al. | β | 2015 | β |
| Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity. | Pedraz M et al. | β | 2015 | β |
| Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity. | Araos P et al. | β | 2015 | β |
| Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: Substance abusers and others in the general population. | Hasin DS et al. | β | 2015 | β |
| The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. | Hasin DS et al. | β | 2015 | β |
| The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample. | Grant BF et al. | β | 2015 | β |
| The influence of age and gender on the likelihood of endorsing cannabis abuse/dependence criteria. | Delforterie MJ et al. | β | 2015 | β |
| Alcohol consumption mediates the relationship between ADH1B and DSM-IV alcohol use disorder and criteria. | Kilcoyne B et al. | β | 2014 | β |
| A pilot study of brief heart rate variability biofeedback to reduce craving in young adult men receiving inpatient treatment for substance use disorders. | Eddie D et al. | β | 2014 | β |
| Comparing factor, class, and mixture models of cannabis initiation and DSM cannabis use disorder criteria, including craving, in the Brisbane longitudinal twin study. | Kubarych TS et al. | β | 2014 | β |
| Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients. | Kelly SM et al. | β | 2014 | β |
| Craving as an alcohol use disorder symptom in DSM-5: an empirical examination in a treatment-seeking sample. | Murphy CM et al. | β | 2014 | β |
| DSM-5 cannabis use disorder: a phenotypic and genomic perspective. | Agrawal A et al. | β | 2014 | β |
| Evaluation of the diagnostic criteria of Internet gaming disorder in the DSM-5 among young adults in Taiwan. | Ko CH et al. | β | 2014 | β |
| Item response theory analyses of DSM-IV and DSM-5 stimulant use disorder criteria in an American Indian community sample. | Gilder DA et al. | β | 2014 | β |
| Parental alcohol history differentially predicts offspring disorders in distinct subgroups in Israel. | Meyers JL et al. | β | 2014 | β |
| Trauma exposure, posttraumatic stress disorder and risk for alcohol, nicotine, and marijuana dependence in Israel. | Walsh K et al. | β | 2014 | β |
| Assessment of a modified DSM-5 diagnosis of alcohol use disorder in a genetically informative population. | Edwards AC et al. | β | 2013 | β |
| Clinical practice. Alcohol use in adults. | Friedmann PD | β | 2013 | β |
| Craving: a research update: editorial to a special issue. | Kavanagh DJ et al. | β | 2013 | β |
| DSM-5 criteria for substance use disorders: recommendations and rationale. | Hasin DS et al. | β | 2013 | β |
| Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity. | PavΓ³n FJ et al. | β | 2013 | β |
| Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample. | Peer K et al. | β | 2013 | β |
| Rasch model of the GAIN substance problem scale among Canadian adults seeking residential and outpatient addiction treatment. | Kenaszchuk C et al. | β | 2013 | β |
| The Puzzling Unidimensionality of DSM-5 Substance Use Disorder Diagnoses. | Maccoun RJ | β | 2013 | β |
| Validity of proposed DSM-5 diagnostic criteria for nicotine use disorder: results from 734 Israeli lifetime smokers. | Shmulewitz D et al. | β | 2013 | β |
| An assessment of the compatibility of DSM-IV and proposed DSM-5 criteria in the diagnosis of cannabis use disorders. | Kopak AM et al. | β | 2012 | β |
| Combining abuse and dependence in DSM-5. | Hasin DS | β | 2012 | β |